Franklin Resources
AXSM icon

Franklin Resources’s Axsome Therapeutics AXSM Stock Holding History

Franklin Resources’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$164M Buy
668,373
+229,883
+52% +$49.9M 0.04% 348
2026
Q1 		$74.1M Buy
438,490
+95,917
+28% +$16.6M 0.02% 519
2025
Q4 		$62.6M Buy
342,573
+56,975
+20% +$7.95M 0.02% 572
2025
Q3 		$34.7M Buy
285,598
+7,088
+3% +$798K 0.01% 768
2025
Q2 		$29.1M Buy
278,510
+51,995
+23% +$5.51M 0.01% 810
2025
Q1 		$26.4M Buy
226,515
+44,225
+24% +$5.04M 0.01% 820
2024
Q4 		$15.4M Buy
182,290
+21,756
+14% +$2M ﹤0.01% 979
2024
Q3 		$13.7M Buy
160,534
+51,696
+47% +$4.51M ﹤0.01% 1009
2024
Q2 		$8.76M Buy
108,838
+967
+0.9% +$71.6K ﹤0.01% 1122
2024
Q1 		$8.61M Buy
107,871
+104,325
+2,942% +$8.76M ﹤0.01% 1138
2023
Q4 		$282K Buy
3,546
+11
+0.3% +$735 ﹤0.01% 2206
2023
Q3 		$247K Sell
3,535
-1,306
-27% -$97.6K ﹤0.01% 2238
2023
Q2 		$348K Buy
4,841
+1,498
+45% +$111K ﹤0.01% 2141
2023
Q1 		$206K Buy
3,343
+591
+21% +$38.8K ﹤0.01% 1990
2022
Q4 		$212K Buy
+2,752
New +$164K ﹤0.01% 1988

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Franklin Resources's AXSM Position: Q2 2026 in Review

Franklin Resources increased its Axsome Therapeutics (AXSM) stake by 52% in Q2 2026, buying an estimated $49.9M and bringing the position to 668,373 shares worth $164M. The position accounts for 0.04% of the portfolio, ranked #348.

Franklin Resources first reported a position in AXSM in Q4 2022 and has held it in 15 quarters since. 504 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Franklin Resources held 668,373 shares of Axsome Therapeutics worth $164M as of Q2 2026.
  • Franklin Resources bought 229,883 Axsome Therapeutics shares in Q2 2026, an estimated $49.9M.
  • Axsome Therapeutics made up 0.04% of Franklin Resources's portfolio in Q2 2026, its #348 holding.
  • Franklin Resources first reported a position in Axsome Therapeutics in Q4 2022 and has held it in 15 quarters since.
  • 504 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.